stockrow
Friday 6 November 2026
Export CASIF’s income statement to Excel — free account
CASI Pharmaceuticals Inc.
CASIF Healthcare Biotechnology
CASI Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.7 million, down 27.4% from fiscal 2024.
- Revenue
- −45.9%
- EPS
- +35.8%
- Free cash flow
- −23,251.7%
- Total debt
- +6.97%
Quarter to December 2025, against a year earlier
0.11
0.01
+10.00%
Follow CASIF
Alert me
| Older periods | Jun '25 | Sep '25 | Dec '25 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
— | — | 3 | — |
| 830.72% | 669.76% | 271.28% | 0.00% | ||
| (113.71%) | (112.12%) | (121.17%) | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
385.20% | 242.48% | 164.33% | 0.00% | |
Average Days of Receivables |
62.02 | 35.47 | 72.11 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | (3.80) | — | |
Free Cash Flow |
— | — | (70.46) | — | |
Capital Expenditures |
— | — | (1.55) | — | |
| Other line items | |||||
Cash ROIC |
0.00% | 0.00% | 857.53% | 0.00% | |
Accounts Receivable Turnover |
4.82 | 3.90 | 2.13 | 0.00 | |
Accounts Payable Turnover |
23.31 | 14.83 | 5.62 | 0.00 | |
Inventory Turnover |
2.07 | 2.22 | 3.11 | 0.00 | |
Average Days of Payables |
15.79 | 11.86 | 36.55 | 0.00 | |
Days of Inventory on Hand |
66.61 | 55.30 | 54.84 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | — | |
Research and Development Expense of Revenue |
28.03% | 32.55% | 30.46% | — | |
Selling, General and Administrative Expense of Revenue |
144.13% | 165.46% | 225.06% | — | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 62.42% | — | |
Interest Coverage |
(45.67) | (48.52) | (51.01) | — | |
Operating CF/Net income |
0.00 | 0.00 | 1.43 | — | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.75 | 0.00 | |
Capex/Depreciation |
— | — | (0.30) | — | |
Revenue per Share |
2.04 | 1.67 | 1.12 | — | |
Operating CF per Share |
0.00 | 0.00 | (3.72) | — | |
Capex per Share |
0.00 | 0.00 | (0.08) | — | |
Capex to Sales |
0.00 | 0.00 | 0.07 | — |
Columns are period end dates · fundamentals updated 25 Oct 2026